These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8032114

  • 1. Malignant liver disease in alpha 1-antitrypsin deficiency.
    Poley JR.
    Acta Paediatr Suppl; 1994 Feb; 393():27-32. PubMed ID: 8032114
    [No Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ).
    Rawlings W, Moss J, Cooper HS, Hamilton SR.
    Ann Intern Med; 1974 Dec; 81(6):771-3. PubMed ID: 4372920
    [No Abstract] [Full Text] [Related]

  • 3. Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas.
    Imai Y, Oda H, Arai M, Shimizu S, Nakatsuru Y, Inoue T, Ishikawa T.
    Jpn J Cancer Res; 1996 Oct; 87(10):1056-62. PubMed ID: 8957064
    [Abstract] [Full Text] [Related]

  • 4. Is there a relationship between alpha-1-antitrypsin Pi MZ phenotype and hepatoma?
    Charlionet R, Martin JP, Sesboué R, Ropartz C.
    Biomedicine; 1976 Jun; 25(4):125-6. PubMed ID: 60146
    [No Abstract] [Full Text] [Related]

  • 5. Alpha-1-antitrypsin phenotypes in adult liver disease patients.
    Topic A, Alempijevic T, Milutinovic AS, Kovacevic N.
    Ups J Med Sci; 2009 Jun; 114(4):228-34. PubMed ID: 19961268
    [Abstract] [Full Text] [Related]

  • 6. Emphysema, cirrhosis, and hepatoma with alpha-1 antitrypsin deficiency.
    Lieberman J.
    Ann Intern Med; 1974 Dec; 81(6):850-2. PubMed ID: 4372921
    [No Abstract] [Full Text] [Related]

  • 7. [Gene TP53 and digestive cancers].
    Tominaga O, Salmon RJ, Laurent-Puig P.
    Gastroenterol Clin Biol; 1993 Dec; 17(3):187-96. PubMed ID: 8392475
    [No Abstract] [Full Text] [Related]

  • 8. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma.
    Rabinovitz M, Gavaler JS, Kelly RH, Prieto M, Van Thiel DH.
    Hepatology; 1992 Mar; 15(3):407-10. PubMed ID: 1312055
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alpha-1-antitrypsin deficiency and liver diseases in Nigeria.
    Olusi SO.
    Trop Geogr Med; 1990 Jan; 42(1):41-6. PubMed ID: 2175465
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease: a prospective study in more than 100 patients.
    Müller P, Ostwald C, Püschel K, Brinkmann B, Plath F, Kröger J, Barten M, Nizze H, Schareck WD, Hauenstein K, Liebe S, Löhr JM.
    Eur J Clin Invest; 2001 Mar; 31(3):240-7. PubMed ID: 11264652
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype).
    Lieberman J, Silton RM, Agliozzo CM, McMahon J.
    Am J Clin Pathol; 1975 Sep; 64(3):304-10. PubMed ID: 169686
    [Abstract] [Full Text] [Related]

  • 15. [A comparison study of immunohistochemical detection of ras P21 and N-ras mRNA in situ hybridization in hepatocellular carcinoma and pericancerous nontumor liver tissue].
    Bu H.
    Zhonghua Bing Li Xue Za Zhi; 1991 Mar; 20(1):11-3. PubMed ID: 1648455
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Loss of heterozygosity and microsatellite instability in human non-neoplastic hepatic lesions.
    Tsopanomichalou M, Kouroumalis E, Ergazaki M, Spandidos DA.
    Liver; 1999 Aug; 19(4):305-11. PubMed ID: 10459629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.
    Hosny G, Farahat N, Tayel H, Hainaut P.
    Cancer Lett; 2008 Jun 18; 264(2):201-8. PubMed ID: 18313840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.